VIM Protein

VIM Protein (Vimentin)

Pathway Diagram

```mermaid
flowchart TD
VIM["VIM<br/>(Vimentin)"]

%% Autophagy pathway
BECN1["BECN1<br/>(Beclin-1)"]
MAP1LC3B["MAP1LC3B<br/>(LC3B)"]
ATG14["ATG14<br/>(Autophagy Protein)"]
PIK3C3["PIK3C3<br/>(VPS34)"]
UVRAG["UVRAG<br/>(Autophagy Regulator)"]
LAMP1["LAMP1<br/>(Lysosomal Protein)"]
Autophagy["Autophagy<br/>Pathway"]

%% Protein degradation
UPS["Ubiquitin-Proteasome<br/>System"]
HDAC6["HDAC6<br/>(Histone Deacetylase)"]

%% Cellular stress
H2AX["H2AX<br/>(DNA Damage Marker)"]
MAP3K5["MAP3K5<br/>(ASK1 Kinase)"]

%% Disease outcomes
Inflammation["Neuroinflammation"]
Senescence["Cellular<br/>Senescence"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
PD["Parkinson's<br/>Disease"]
MS["Multiple<br/>Sclerosis"]

%% Connections
VIM -->|"regulates"| BECN1
VIM -->|"regulates"| ATG14
VIM -->|"regulates"| Autophagy
VIM -->|"associated with"| MAP1LC3B
VIM -->|"associated with"| PIK3C3
VIM -->|"associated with"| UVRAG
VIM -->|"associated with"| LAMP1
VIM -->|"regulates"| UPS
VIM -->|"associated with"| HDAC6
VIM -->|"regulates"| H2AX
VIM -->|"associated with"| MAP3K5

BECN1 -->|"initiates"| Autophagy
ATG14 -->|"promotes"| Autophagy
MAP1LC3B -->|"mediates"| Autophagy
PIK3C3 -->|"activates"| Autophagy
UVRAG -->|"regulates"| Autophagy
LAMP1 -->|"completes"| Autophagy

VIM -->|"biomarker for"| Inflammation
VIM -->|"biomarker for"| Senescence
VIM -->|"biomar

VIM Protein (Vimentin)

Pathway Diagram

Introduction

Vim Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>VIM (Vimentin)</td></tr>
<tr><th>Gene</th><td>[VIM](/genes/vim)</td></tr>
<tr><th>UniProt ID</th><td>[P08670](https://www.uniprot.org/uniprotkb/P08670)</td></tr>
<tr><th>PDB ID</th><td>1GK4, 3KLT, 4YV3</td></tr>
<tr><th>Molecular Weight</th><td>54 kDa (466 amino acids)</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, intermediate filaments, perinuclear region</td></tr>
<tr><th>Protein Family</th><td>Type III intermediate filament family</td></tr>
<tr><th>Brain Expression</th><td>Neurons, astrocytes, oligodendrocytes, microglia</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Multiple Sclerosis</td></tr>
</table>
</div>

Overview

Vimentin is a type III intermediate filament protein encoded by the [VIM](/genes/vim) gene that serves as a key structural component of the cytoskeleton in various cell types, including [neurons](/entities/neurons) and glial cells. In the central nervous system, vimentin is expressed predominantly in [astrocytes](/entities/astrocytes), [microglia](/entities/microglia), and neural progenitor cells, with lower expression in mature neurons under normal conditions[@herrmann2007]. Vimentin plays critical roles in maintaining cellular architecture, facilitating intracellular transport, regulating signal transduction pathways, and responding to cellular stress[@pekny2019].

The protein is particularly notable for its upregulation in reactive astrocytes (a process termed astrocytosis or glial scarring) in response to neurodegeneration, making it a widely used marker for assessing neuroinflammatory responses in neurodegenerative disease[@shabbir2014]. Beyond its structural functions, vimentin participates in numerous protein-protein interactions that regulate apoptosis, autophagy, mitochondrial dynamics, and immune responses—all processes central to neurodegeneration[@eriksson2009].

Structure

Vimentin exhibits the characteristic architecture of type III intermediate filament proteins:

Primary Structure

• Length: 466 amino acids
• Molecular weight: ~54 kDa
• Isoforms: Multiple splice variants exist, including vimentin-v (a shorter variant)

Domain Organization

Quaternary Structure

Vimentin assembles into a hierarchical structure:

• Two polypeptides form a coiled-coil dimer (the basic unit)
• Two dimers associate to form a tetramer (soluble subunit)
• Tetramers assemble into unit-length filaments
• Filaments bundle together to form 10nm intermediate filaments

Post-Translational Modifications

Vimentin undergoes extensive post-translational modifications:

• Phosphorylation: Multiple serine/threonine kinases (PKC, CaMKII, Aurora B) phosphorylate vimentin, regulating filament disassembly during mitosis and stress responses[@goto1998]
• Methylation: Arginine methylation affects protein interactions
• Acetylation: Lysine acetylation influences filament stability
• SUMOylation: SUMO modification affects subcellular localization

Normal Function

Cytoskeletal Architecture

Vimentin provides mechanical support and maintains cellular integrity:

• Forms a dynamic network extending from the nucleus to the plasma membrane
• Coordinates organelle positioning, particularly mitochondria
• Supports axonal and dendritic structure in neurons
• Facilitates cell migration and process extension

Astrocyte Function

In astrocytes, vimentin:

• Partners with [GFAP](/proteins/gfap-protein) to form intermediate filament networks
• Supports astrocyte morphology and process stability
• Enables astrocyte migration during development and injury response
• Facilitates calcium wave propagation through the astrocyte network

Neural Development

During development, vimentin:

• Guides neural crest cell migration
• Supports radial glial cell scaffolding for neuronal migration
• Enables process outgrowth in developing neurons
• Facilitates synapse formation and remodeling

Cellular Homeostasis

Vimentin regulates:

• Mitochondrial distribution and quality control: Vimentin cages surround mitochondria, facilitating proper distribution and selective removal of damaged organelles[@tang2019]
• [Autophagy](/entities/autophagy): Interacts with autophagy receptors to facilitate clearance of protein aggregates
• [Apoptosis](/entities/apoptosis): Modulates caspase activation and apoptotic signaling
• Cell signaling: Serves as scaffold for various signaling pathways (MAPK, PI3K/Akt)

Role in Neurodegenerative Diseases

Alzheimer's Disease

Vimentin pathology in AD is extensive and multifaceted:

Astrocytic Reactivity
Vimentin is dramatically upregulated in reactive astrocytes surrounding [amyloid-beta](/proteins/amyloid-beta) plaques[@kahlson2022]. These vimentin-positive astrocytes exhibit:

• Hypertrophic morphology with enlarged processes
• Increased [GFAP](/entities/gfap) and vimentin co-expression
• Enhanced inflammatory cytokine production

• Vimentin can be incorporated into aberrant filamentous structures
• Cross-linking with [tau protein](/proteins/tau) may stabilize pathological aggregates
• Phosphorylation patterns in vimentin mirror [tau](/proteins/tau) pathology

• Vimentin in astrocyte end-feet contributes to BBB maintenance
• Disruption of vimentin networks correlates with BBB leakage in AD
• Altered vimentin affects [astrocyte](/cell-types/astrocytes) uptake of Aβ

Parkinson's Disease

Microglial Activation

• Vimentin is upregulated in activated [microglia](/cell-types/microglia-neuroinflammation) in the substantia nigra
• Vimentin-positive microglia cluster around dopaminergic neurons
• Correlates with disease severity and progression

• Vimentin may facilitate [alpha-synuclein](/proteins/alpha-synuclein) aggregation
• Interacts with Lewy body structures
• May influence prion-like spread of [α-synuclein](/proteins/alpha-synuclein) pathology

• Vimentin released from damaged cells acts as DAMP (damage-associated molecular pattern)
• Triggers [TLR4](/entities/tlr4)-mediated inflammatory responses
• Amplifies microglial activation in a feed-forward manner

Amyotrophic Lateral Sclerosis (ALS)

Astrocytic Dysfunction

• Upregulated in astrocytes in ALS models and patients
• Contributes to non-cell autonomous neuronal death
• Vimentin-positive astrocytes show impaired glutamate uptake

• Vimentin interacts with [TDP-43](/proteins/tardbp-protein) aggregates (pathological hallmark of ALS)
• May sequester clearance machinery
• Affects autophagy-lysosomal pathway function

Multiple Sclerosis

Glial Scarring

• Vimentin is a major component of the glial scar
• Upregulated in reactive astrocytes around demyelinating lesions
• Both beneficial (containing inflammation) and detrimental (inhibiting repair) roles

• Vimentin expressed in OPCs during migration
• Necessary for proper OPC differentiation
• Dysregulation may impair remyelination

Therapeutic Implications

Biomarker Potential

Vimentin shows promise as a biomarker:

• CSF biomarker: Vimentin levels elevated in CSF of AD and PD patients[@olsson2016]
• Blood biomarker: Peripheral blood monocyte vimentin expression correlates with disease state
• Imaging target: PET ligands targeting vimentin-reactive astrocytes under development

Therapeutic Targets

Reducing Vimentin Expression

• Antisense oligonucleotides targeting VIM reduce astrocyte reactivity
• CRISPR-based approaches show promise in preclinical models
• Must balance beneficial (anti-inflammatory) and detrimental (support deficits) effects

• Kinase inhibitors (e.g., PKC inhibitors) reduce vimentin phosphorylation
• May decrease astrocyte reactivity and neuroinflammation

• Inhibition of vimentin secretion as DAMP
• Neutralizing antibodies against extracellular vimentin
• Reduces microglial activation

Drug Development

Several strategies are being explored:

• Small molecule inhibitors: Targeting vimentin polymerization
• Natural compounds: Curcumin and other polyphenols affect vimentin dynamics
• Gene therapy: AAV-mediated VIM knockdown in astrocytes

Interactions and Pathways

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| [GFAP](/proteins/gfap-protein) | Heterodimer formation | Astrocyte IF network |
| [Tau](/proteins/tau) | Co-aggregation | NFT formation |
| [α-Synuclein](/proteins/alpha-synuclein) | Binding | Lewy body formation |
| [TDP-43](/proteins/tdp-43) | Co-aggregation | ALS pathology |
| Beclin-1 | Autophagy regulation | Mitophagy |
| Parkin | Mitochondrial quality control | PD pathogenesis |

Signaling Pathways

• MAPK/ERK pathway: Vimentin phosphorylation regulates activation
• PI3K/Akt: Vimentin scaffold enables downstream signaling
• [NF-κB](/entities/nf-kb): Vimentin supports inflammatory gene expression
• JNK/c-Jun: Stress-activated kinase phosphorylates vimentin

Research Techniques

Detection Methods

• Immunohistochemistry: Antibodies against vimentin (clone V9) widely used
• Western blot: 57 kDa band detected under reducing conditions
• ELISA: Quantifies soluble vimentin in biofluids
• PET imaging: Novel tracers for reactive astrocytes

Model Systems

• Vimentin knockout mice: Viable and fertile, but show wound healing deficits
• Transgenic models: Human VIM overexpression under astrocyte promoters
• iPSC-derived astrocytes: Patient-specific models for disease modeling

Background

The study of Vim Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• VIM Gene
• [GFAP Protein](/proteins/gfap-protein)
• [Astrocytes](/cell-types/astrocytes)
• [Microglia](/cell-types/microglia)
• Intermediate Filaments
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease-mechanisms)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-mechanisms)
• [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
• Glial Scarring